第三届中国国际供应链促进博览会（简称 "链博会"）于 2025 年 7 月 16 日至 20 日在北京举办，作为全球首个以供应链为主题的国家级展会，此次展会首次 移师夏季，以 "链接世界、共创未来" 为主题，实现了简约、务实、精彩的圆满成功。 展会规模再创新高，吸引超过 1200 家中外企业和机构参展，线上线下观众超 21 万人次，较上届增长 5%；172 个境外团组参会，是上届的 2.2 倍。展会强 化 "链式逻辑"，通过大数据和人工智能技术升级 "找朋友" 3.0 模式，精准匹配企业与专业观众 2.4 万次，促成合作协议及意向超 6000 项，参展商首发首展 首秀 152 项新产品新技术新服务，同比增长 67%。截至展会落幕，已有 102 家企业和机构签约第四届参展，同比增长 50%。 传播方面成效显著，全网相关信息量达 26.87 万篇 / 条，较上届增长 34.8%。传播渠道实现全网覆盖，网媒与 "两微一端" 成为核心引擎，中央媒体、地方媒 体、行业媒体及境外媒体协同发力，2000 余名中外记者注册参会，境外主流媒体报道超 2.6 万篇，覆盖 110 个国家 / 地区。传播内容聚焦展会亮点、合作成 果 ...

Group 1 - The third China International Supply Chain Promotion Expo showcases the integration of China's complete production and supply chain with the global industrial chain, highlighting the confidence in "China's international trade" [1] - GE Healthcare emphasizes its role in promoting high-quality development of domestic medical device manufacturing, having built a comprehensive "research, production, sales, and service" system with over 1,000 suppliers [2] - The expo features innovative medical devices, such as a portable ultrasound device from BGI that bridges the gap in medical resources between urban and rural areas, enhancing accessibility to healthcare [2][4] Group 2 - BGI's new coffee metabolism gene testing product allows consumers to receive personalized caffeine consumption advice, demonstrating the integration of genetic technology into everyday life [4] - Huaxi Biological's global largest pilot transformation platform, with an investment exceeding 1 billion yuan and an area of 30,000 square meters, aims to address challenges in the transition from laboratory to market [5] - Medtronic's first locally manufactured cardiac pacing catheter, designed with insights from Chinese clinical experts, represents a significant step in localizing production while serving global markets [8] Group 3 - GE Healthcare reports that over 50% of products sold in the Chinese market are developed locally, with an annual procurement amount nearing 10 billion yuan [8] - The Boao Lecheng International Medical Tourism Pilot Zone is positioned as a core channel for international innovative drugs and medical devices entering China, supported by favorable policies [8] - The integration of clinical, research, and industrial ecosystems in Lecheng is highlighted as a core competitive advantage for China in connecting with the global health industry [8]